At the Extraordinary General Meeting held on January 17, 2024, the shareholders adopted an ordinary resolution by vote. The resolution involved the granting of a share option to Dr. Yang under the Employee Stock Ownership Scheme after the initial public offering to subscribe for a total of 14,000,000 shares. The resolution received over 50% in favor, with 246,205,900 votes in favor, 57,631,303 votes against, for a total of 303,837,203 votes. Dr. Yang and his contacts waived the vote on the resolution. The Extraordinary General Meeting was attended by a number of directors, including Dr. Li Wei, Dr. Yang Jianxin, etc., and Mr. Lin Shuanghong and Dr. Paul Herbert Chew were unable to attend due to other matters. The Central Securities Registry of Hong Kong Limited was appointed as a surveyor to monitor the voting process.

At the Extraordinary General Meeting held on January 17, 2024, the shareholders adopted an ordinary resolution by vote. The resolution involved the granting of a share option to Dr. Yang under the Employee Stock Ownership Scheme after the initial public offering to subscribe for a total of 14,000,000 shares. The resolution received over 50% in favor, with 246,205,900 votes in favor, 57,631,303 votes against, for a total of 303,837,203 votes. Dr. Yang and his contacts waived the vote on the resolution. The Extraordinary General Meeting was attended by a number of directors, including Dr. Li Wei, Dr. Yang Jianxin, etc., and Mr. Lin Shuanghong and Dr. Paul Herbert Chew were unable to attend due to other matters. The Central Securities Registry of Hong Kong Limited was appointed as a surveyor to monitor the voting process.